Corpus Intelligence IC Memo — KINDRED HOSPITAL LIMA 2026-04-26 12:30 UTC
IC Memo — KINDRED HOSPITAL LIMA
Investment Committee Memorandum | OH | 26 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KINDRED HOSPITAL LIMA

CCN 362020 | ALLEN, OH | 26 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KINDRED HOSPITAL LIMA is a 26-bed suburban community hospital in ALLEN, OH with $17.2M in net patient revenue and a 16.3% operating margin. The hospital serves a payer mix of 37.4% Medicare, 3.5% Medicaid, and 59.2% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.3% to 23.7% (+736bps).

Net Revenue HCRIS$17.2M
Current EBITDA COMPUTED$2.8M
Operating Margin COMPUTED16.3%
Occupancy HCRIS74.5%
Revenue / Bed COMPUTED$663K
Net-to-Gross HCRIS21.6%
Distress Probability ML42.4%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
86
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 16.3% places it above the state median. Among 86 size-comparable peers (13-52 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (13-52), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KINDRED HOSPITAL LIMA (Target)OH26$17.2M16.3%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
AVITA ONTARIO HOSPITALOH49$109.2M16.0%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
ALLIANCE COMMUNITY HOSPITALOH50$100.2M-3.5%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$362K+210bp18mo
Cost to Collect4.5%2.5%$345K+200bp12mo
Denial Rate Reduction12.0%6.5%$341K+198bp12mo
A/R Days Reduction5200.0%3800.0%$210K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$362K
Cost to Collect
$345K
Denial Rate Reduction
$341K
A/R Days Reduction
$210K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$2.8M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$4.1M
Current Margin16.3%
Pro Forma Margin23.7%
WC Released (1x)$661K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.3M$31.2M7.22x48.5%
Base (11x exit)10.0x11.0x$4.3M$35.7M8.27x52.6%
Bull Case9.0x11.0x$3.9M$41.3M10.63x60.4%
Bull (12x exit)9.0x12.0x$3.9M$46.2M11.89x64.1%
Bear Case11.0x10.0x$4.8M$23.5M4.94x37.6%
Bear (11x exit)11.0x11.0x$4.8M$27.4M5.76x41.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 13-52 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-12.2% / P50=-2.5% / P75=10.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.